Sol-Gel Technologies Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Longevity Investing
PolarityTE™ Provides Business Updates on Clinical Use of SkinTE: Regeneration of Full-Thickness Skin Pharmaceutical Investing
EyeGate Announces Top-Line Results for Phase 2b Trial of EGP-437 in Cataract Surgery Pharmaceutical Investing
Sorrento’s and Yuhan’s Joint Venture, ImmuneOncia, receives Approval to begin clinical trial of Anti-PD-L1 Biotech Investing
Paratek Completes Submission of New Drug Applications to U.S. Food and Drug Administration Pharmaceutical Investing
AMAG Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for Feraheme Pharmaceutical Investing
